Discover
CDMO
Avid Bioservices, Inc.
12.49
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | 1.13% | |
| 1y | 55.16% |
12.49
day range
12.49
52 week range
| Open | 12.49 | Prev Close | 12.49 | Low | 12.49 | High | 12.49 | Mkt Cap | N/A |
| Vol | 0.00 | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -175.29 |
| Beta | 1.41 | Short Ratio | 3.19 | Inst. Own | 104.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 12.88 |
| Income Statement | |||
| Total Revenue | 33.48M | ||
| Revenues (USD) | 33.48M | ||
| Cost of Revenue | 35.53M | ||
| Gross Profit | -2.04M | ||
| Operating Expenses | 10.59M | ||
| Selling, General and Administrative Expense | 10.59M | ||
| Operating Income | -12.63M | ||
| Interest Expense | 3.28M | ||
| Net Income | -17.41M | ||
| Net Income Common Stock | -17.41M | ||
| Net Income Common Stock (USD) | -17.41M | ||
| Consolidated Income | -17.41M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -14.13M | ||
| Earning Before Interest & Taxes (USD) | -14.13M | ||
| Weighted Average Shares | 63.84M | ||
| Weighted Average Shares Diluted | 63.84M | ||
| Balance Sheet | |||
| Cash and Equivalents | 33.42M | ||
| Cash and Equivalents (USD) | 33.42M | ||
| Trade and Non-Trade Receivables | 18.41M | ||
| Current Assets | 96.51M | ||
| Property, Plant & Equipment Net | 222.57M | ||
| Total Assets | 323.48M | ||
| Debt Current | 1.45M | ||
| Total Debt | 205.53M | ||
| Current Liabilities | 74.16M | ||
| Debt Non-Current | 204.08M | ||
| Total Liabilities | 278.67M | ||
| Accumulated Retained Earnings (Deficit) | -594.81M | ||
| Shareholders Equity | 44.81M | ||
| Shareholders Equity (USD) | 44.81M | ||
| Assets Non-Current | 226.98M | ||
| Total Debt (USD) | 205.53M | ||
| Deferred Revenue | 51.67M | ||
| Inventory | 28.07M | ||
| Liabilities Non-Current | 204.52M | ||
| Trade and Non-Trade Payables | 9.25M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.97M | ||
| Net Cash Flow from Financing | -513.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 34.00K | ||
| Capital Expenditure | -3.45M | ||
| Issuance (Purchase) of Equity Shares | 109.00K | ||
| Issuance (Repayment) of Debt Securities | -622.00K | ||
| Net Cash Flow from Investing | -3.45M | ||
| Net Cash Flow from Operations | 3.99M | ||
| Share Based Compensation | 3.47M | ||